Influence of GYKI-13504, a new antioestrogen, on the responsiveness of isolated uterus removed from oestradiol pretreated rats to PGF2 alpha.
The responsiveness of the uteri of ovariectomized rats pretreated either with E2 or with a new antioestrogen, GYKI-13504 or with both agents simultaneously to PGF2 alpha was studied in vitro. The treatment with E2 caused a fortyfold reduction in the responsiveness of the uterus to PGF2 alpha. GYKI-13504 itself did not influence the sensitivity of this organ significantly, but inhibited the diminishing effect of E2.